Why Am I Always So Tired?
WebMD explains conditions that might cause you to feel sluggish during the day, such as anemia, thyroid trouble, sleep apnea, diabetes, heart disease, depression, and menopause. (Source: WebMD Health)
Source: WebMD Health - November 15, 2023 Category: Consumer Health News Source Type: news
AHA: No Real Benefit Seen for Liberal Transfusion Strategy in AMI, Anemia
TUESDAY, Nov. 14, 2023 -- For patients with acute myocardial infarction and anemia, a liberal transfusion strategy does not significantly reduce the risk for recurrent myocardial infarction or death compared with a restrictive strategy, according to... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 14, 2023 Category: Pharmaceuticals Source Type: news
In MI With Anemia, Results May Favor Liberal Transfusion In MI With Anemia, Results May Favor Liberal Transfusion
Although the primary outcome was not statistically different between a liberal and more restrictive transfusion strategy, secondary results suggest some advantages for the liberal approach.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - November 11, 2023 Category: Internal Medicine Tags: Cardiology News Source Type: news
‘The Marvels’ Sinks to MCU-Low $48 Million Box Office Opening
“The Marvels” will set a new record for the worst opening weekend in the history of the Marvel Cinematic Universe, as the sequel to 2019’s “Captain Marvel” posted an anemic $21.3 million Friday total and is heading towards a $48 million domestic launch from 4,030 theaters, according to industry…#marvels #captainmarvel #marvelstudios #incrediblehulk #flash #cinemascore #mcu #secretinvasion #thewrap (Source: Reuters: Health)
Source: Reuters: Health - November 11, 2023 Category: Consumer Health News Source Type: news
Different transfusion approaches for helping heart attack patients who develop anemia recover led to similar 30-day outcomes
NIH-funded findings suggest potential benefit of giving more blood to patients. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - November 11, 2023 Category: American Health Source Type: news
Transfusion Thresholds Square Off in Acute Myocardial Infarction
(MedPage Today) -- PHILADELPHIA -- For acute myocardial infarction (MI) patients with anemia, being more liberal with blood transfusion thresholds didn't significantly impact risk of recurrent heart attack or death in the MINT trial, although... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - November 11, 2023 Category: Cardiology Source Type: news
FDA considers first CRISPR gene editing treatment that may cure sickle cell
At age 45, Dr. Lakiea Bailey said, for the longest time, that she was the oldest person with sickle cell anemia that she knew. The executive director of the nonprofit patient advocacy group the Sickle Cell Consortium was diagnosed with sickle cell disease at age three. Because of it, she’s had…#lakieabailey #sicklecellconsortium #bailey #fda #boston #crispr #africanamericans #stephaniekrogmeier #fyodorurnov #independentcommittee (Source: Reuters: Health)
Source: Reuters: Health - November 1, 2023 Category: Consumer Health News Source Type: news
Panel Tells F.D.A. That CRISPR Sickle Cell Cure Is Safe Enough for Patients
The decision by an advisory committee may lead to Food and Drug Administration approval of the first treatment for humans that uses the CRISPR gene-editing system. (Source: NYT Health)
Source: NYT Health - October 31, 2023 Category: Consumer Health News Authors: Gina Kolata Tags: Sickle Cell Anemia Crispr (DNA) Food and Drug Administration Vertex Pharmaceuticals Inc CRISPR Therapeutics Clinical Trials Genetic Engineering Drugs (Pharmaceuticals) Source Type: news
New Gene Therapies for Sickle Cell Anemia to be Considered by FDA
MONDAY, Oct. 30, 2023 -- Patients with sickle cell disease may soon have two new treatments to try. On Tuesday, a U.S. Food and Drug Administration advisory committee will weigh the merits of a new gene therapy for the painful, inherited condition.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 30, 2023 Category: Pharmaceuticals Source Type: news
FDA Advisers to Weigh New Gene Therapies for Sickle Cell Anemia
MONDAY, Oct. 30, 2023 -- Patients with sickle cell disease may soon have two new treatments to try. On Tuesday, a U.S. Food and Drug Administration advisory committee will weigh the merits of a new gene therapy for the painful, inherited condition.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 30, 2023 Category: Pharmaceuticals Source Type: news
F.D.A. Experts Will Vote on Safety of a Cure for Sickle Cell Disease
The treatment from the company Vertex would be the first medicine to use the gene editing tool CRISPR. (Source: NYT Health)
Source: NYT Health - October 30, 2023 Category: Consumer Health News Authors: Gina Kolata Tags: Sickle Cell Anemia Food and Drug Administration Crispr (DNA) Vertex Pharmaceuticals Inc Genetic Engineering Drugs (Pharmaceuticals) Therapy and Rehabilitation CRISPR Therapeutics Source Type: news
Testosterone Tx Improves Anemia in Male Hypogonadism Testosterone Tx Improves Anemia in Male Hypogonadism
A large RCT found testosterone replacement therapy more effective than placebo in middle-aged and older men with hypogonadism.MDedge News (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - October 30, 2023 Category: Urology & Nephrology Tags: Family Medicine/Primary Care News Source Type: news
Testosterone Efficacious for Correcting Anemia in Middle-Aged Men
MONDAY, Oct. 30, 2023 -- Testosterone replacement therapy (TRT) is efficacious for correcting anemia among middle-aged and older men with hypogonadism and anemia, according to a study published online Oct. 27 in JAMA Network Open.Karol M. Pencina,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 30, 2023 Category: Pharmaceuticals Source Type: news
FDA Advisors to Weigh New Gene Therapy for Sickle Cell Anemia
MONDAY, Oct. 30, 2023 -- Patients with sickle cell disease may soon have two new treatments to try.On Tuesday, a U.S. Food and Drug Administration advisory committee will weigh the merits of a new gene therapy for the painful, inherited... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 30, 2023 Category: General Medicine Source Type: news
Akebia Receives FDA Acceptance of Resubmission to NDA of Vadadustat for the Treatment of Anemia due to Chronic Kidney Disease
CAMBRIDGE, Mass., Oct. 25, 2023 /PRNewswire/ -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced the U.S. Food and Drug... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - October 25, 2023 Category: Drugs & Pharmacology Source Type: news
